Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Clinical trials in CIDP and chronic autoimmune demyelinating polyneuropathies.
Reliability and validity of the function in sitting test in nonambulatory individuals with multiple sclerosis.
Brain cytokines and disease.
The Protective Role of HLA-DRB1(∗)13 in Autoimmune Diseases.
Longitudinal change in magnetic susceptibility of new enhanced multiple sclerosis (MS) lesions measured on serial quantitative susceptibility mapping (QSM).
Oxidative injury in multiple sclerosis cerebellar grey matter.
Neurourologic dysfunction: evaluation, surveillance and therapy.
Proximal nerve lesions in early Guillain-Barré syndrome: implications for pathogenesis and disease classification.
Intracellular and circulating neuronal antinuclear antibodies in human epilepsy.
Erratum: Genomic analysis of ERVWE2 locus in patients with Multiple sclerosis: absence of genetic association but potential role of Human Endogenous retrovirus type W elements in molecular mimicry with myelin antigen.
Vitamin D: not just the bone. Evidence for beneficial pleiotropic extraskeletal effects.
Molecular dynamics and intracellular signaling of the TNF-R1 with the R92Q mutation.
Inhibin-a immunoreactivity in nervous system lesions.
Variations in and predictors of the occurrence of depressive symptoms and mood symptoms in multiple sclerosis: a longitudinal two-year study.
In multiple sclerosis, use of fingolimod reduced immune responses to influenza and tetanus booster vaccines.
[Epidemiology of multiple sclerosis].
Imaging of Proteins in Tissue Samples Using Nanospray Desorption Electrospray Ionization Mass Spectrometry.
Type I/II Interferon Balance in the Regulation of Brain Physiology and Pathology.
Cytoskeletal Linker Protein Dystonin Is Not Critical to Terminal Oligodendrocyte Differentiation or CNS Myelination.
Hypoxia-inducible factor 1 in autoimmune diseases.
Favorable outcome of granulocyte colony-stimulating factor use in neuromyelitis optica patients presenting with agranulocytosis in the setting of rituximab.
Targeting specific cells in the brain with nanomedicines for CNS therapies.
Resveratrol Exacerbates Both Autoimmune and Viral Models of Multiple Sclerosis.
Fatigue and heat sensitivity in patients with multiple sclerosis.
Spatial and temporal characteristics of gait as outcome measures in multiple sclerosis (EDSS 0 to 6.5).

Pages